Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models as valid equivalents for the study of human breast cancer. Here, we performed whole exome and RNA sequencing on long latency mammary tumors (218 ± 27 days) induced by the carcinogen 7,12-Dimethylbenzathracene (DMBA) and short latency tumors (65 ± 11 days) induced by the progestin Medroxyprogesterone Acetate (MPA) plus DMBA in CD2F1 mice. Long latency tumors displayed a high frequency of Pi3kca and/or Pten mutations detected in 11 of 13 (85%) long latency cases (14/22, 64% overall). Eighty-two percent (9/11) of tumors carried the Pik3ca H1047L/R hot-spot mutation, as frequently found in human breast cancer. These tumors were luminal-like and m...
Breast cancer is the most frequent cancer in women and consists of heterogeneous types of tumours th...
Cancer genomics has provided an unprecedented opportunity for understanding genetic causes of human ...
The high incidence of breast cancer cases in the world requires the use of applicative methods. The ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Background: Germline mutations in the tumor suppressor PTEN predispose human beings to breast cancer...
PIK3CA, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is frequently mutated in...
PIK3CA, the gene coding for the p110alpha subunit of phosphoinositide 3-kinase, is frequently mutate...
PIK3CA, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is frequently mutated in...
PIK3CA, the gene coding for the p110a subunit of phosphoinositide 3-kinase, is frequently mutated in...
<div><p><em>PIK3CA</em>, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is freq...
SummaryCancer genomics has provided an unprecedented opportunity for understanding genetic causes of...
Breast cancer is the most frequent cancer in women and consists of heterogeneous types of tumours th...
Cancer genomics has provided an unprecedented opportunity for understanding genetic causes of human ...
The high incidence of breast cancer cases in the world requires the use of applicative methods. The ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models ...
Background: Germline mutations in the tumor suppressor PTEN predispose human beings to breast cancer...
PIK3CA, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is frequently mutated in...
PIK3CA, the gene coding for the p110alpha subunit of phosphoinositide 3-kinase, is frequently mutate...
PIK3CA, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is frequently mutated in...
PIK3CA, the gene coding for the p110a subunit of phosphoinositide 3-kinase, is frequently mutated in...
<div><p><em>PIK3CA</em>, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is freq...
SummaryCancer genomics has provided an unprecedented opportunity for understanding genetic causes of...
Breast cancer is the most frequent cancer in women and consists of heterogeneous types of tumours th...
Cancer genomics has provided an unprecedented opportunity for understanding genetic causes of human ...
The high incidence of breast cancer cases in the world requires the use of applicative methods. The ...